TRIB3 and head and neck squamous cell carcinoma: As depicted in Fig. 8O, we demonstrated the potential of TRIB3 as a prognostic indicator for poor outcomes in HNSCC, unveiling a novel mechanism by which it promotes tumor growth through the inhibition of ferroptosis.